OTLERTUZUMAB Drug Record

  • OTLERTUZUMAB chembl:CHEMBL3039539 Antineoplastic

    Alternate Names:

    TRU-016
    OTLERTUZUMAB

    Drug Info:

    FDA Approval not approved
    Drug Class antibody fragment
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • OTLERTUZUMAB   CD37

    Interaction Score: 61.83

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    Trial Name TRU-016
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TTD

  • TdgClinicalTrial: TRU-016

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class antibody fragment
    FDA Approval not approved

    Publications:

  • TTD: TRU-016

    • Version: 2020.06.01

    Alternate Names:
    D0T7QC TTD Drug ID

    Drug Info:

    Publications:

  • TTD: Otlertuzumab

    • Version: 2020.06.01

    Alternate Names:
    D08JGB TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL3039539

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: